Human Stromal (Mesenchymal) Stem Cells: Basic Biology and Current Clinical Use for Tissue Regeneration

被引:54
作者
Aldahmash, Abdullah [1 ,2 ,3 ]
Zaher, Walid [1 ,2 ,3 ]
Al-Nbaheen, May [2 ,3 ]
Kassem, Moustapha [1 ,2 ,3 ]
机构
[1] King Saud Univ, Stem Cell Unit, Dept Anat, Coll Med, Riyadh 11451, Saudi Arabia
[2] Odense Univ Hosp, Endocrine Res KMEB, Dept Endocrinol, DK-5000 Odense, Denmark
[3] Univ So Denmark, Odense, Denmark
关键词
HUMAN BONE-MARROW; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VERSUS-HOST-DISEASE; ACUTE-RENAL-FAILURE; ACUTE MYOCARDIAL-INFARCTION; CRITICAL-SIZE DEFECTS; UMBILICAL-CORD BLOOD; ADIPOSE-TISSUE; IN-VITRO; MONOLAYER CULTURES;
D O I
10.5144/0256-4947.2012.68
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human stromal (mesenchymal) stem cells (hMSC) represent a group of non-hematopoietic stem cells present in the bone marrow stroma and the stroma of other organs including subcutaneous adipose tissue, placenta, and muscles. They exhibit the characteristics of somatic stem cells of self-renewal and multi-lineage differentiation into mesoderm-type of cells, e.g., to osteoblasts, adipocytes, chondrocytes and possibly other cell types including hepatocytes and astrocytes. Due to their ease of culture and multipotentiality, hMSC are increasingly employed as a source for cells suitable for a number of clinical applications, e.g., non-healing bone fractures and defects and also non-skeletal degenerative diseases like heart failure. Currently, the numbers of clinical trials that employ MSC are increasing. However, several biological and biotechnological challenges need to be overcome to benefit from the full potential of hMSC. In this current review, we present some of the most important and recent advances in understanding of the biology of hMSC and their current and potential use in therapy.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 94 条
[1]  
Abdallah Basem M., 2008, V455, P89, DOI 10.1007/978-1-59745-104-8_6
[2]   Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene in despite of extensive proliferation [J].
Abdallah, BM ;
Haack-Sorensen, M ;
Burns, JS ;
Elsnab, B ;
Jakob, F ;
Hokland, P ;
Kassem, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 326 (03) :527-538
[3]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[4]   Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes [J].
Alvarez-Dolado, M ;
Pardal, R ;
Garcia-Vardugo, JM ;
Fike, JR ;
Lee, HO ;
Pfeffer, K ;
Lois, C ;
Morrison, SJ ;
Alvarez-Buylla, A .
NATURE, 2003, 425 (6961) :968-973
[5]  
Anker PSI, 2003, HAEMATOLOGICA, V88, P845
[6]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[7]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[8]   Novel markers for the prospective isolation of human MSC [J].
Buehring, Hans-Joerg ;
Battula, Venkata Lokesh ;
Treml, Sabrina ;
Schewe, Bernhard ;
Kanz, Lothar ;
Vogel, Wichard .
HEMATOPOIETIC STEM CELLS VI, 2007, 1106 :262-271
[9]   Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].
Campagnoli, C ;
Roberts, IAG ;
Kumar, S ;
Bennett, PR ;
Bellantuono, I ;
Fisk, NM .
BLOOD, 2001, 98 (08) :2396-2402
[10]   Unicameral bone cysts treated by injection of bone marrow or methylprednisolone [J].
Chang, CH ;
Stanton, RP ;
Glutting, J .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B (03) :407-412